Equities

Financiere de Tubize SA

Financiere de Tubize SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)130.20
  • Today's Change-0.40 / -0.31%
  • Shares traded29.34k
  • 1 Year change+85.73%
  • Beta0.6439
Data delayed at least 15 minutes, as of Sep 18 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Financiere de Tubize SA is a Belgium-based holding company. The Company holds minor capital in UCB SA. UCB is a Belgian pharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. UCB, together with its subsidiaries, has research and development facilities in Belgium, Germany, Japan, the United Kingdom and the United States. The Company promotes the development of a sustainable biopharma ecosystem in Belgium and possibly in other geographic areas relevant to UCB.

  • Revenue in EUR (TTM)0.00
  • Net income in EUR183.85m
  • Incorporated1928
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
GlaxoSmithKline Pharmaceuticals Limited376.65m68.75m5.09bn3.21k74.10--66.8013.5237.7737.77206.98--------10,920,890.00--11.01--17.8861.9755.7718.2512.25--490.08--192.076.212.00-2.915.78-36.029.86
Glenmark Pharmaceuticals Ltd1.29bn-168.98m5.19bn14.99k------4.02-55.78-46.50425.96--------8,020,026.00--1.02--1.4363.9359.47-12.711.43--1.78--56.981.983.67-1,018.93---5.894.56
Beijing Tiantan Biological Products Corp676.20m160.99m5.27bn4.86k32.764.03--7.800.64190.64192.705.220.36740.9077222.801,097,335.0011.8611.7117.1116.5053.5449.3932.2827.713.23--0.007416.6721.5712.0625.9916.8529.6738.97
Rohto Pharmaceutical Co Ltd1.76bn191.63m5.31bn7.26k26.853.1521.253.02132.56132.561,215.221,129.950.76422.214.3738,300,730.008.428.5411.7011.7957.7658.5911.0210.301.27--0.151319.3913.488.0917.2825.855.2018.61
Beijing Tongrentang Co Ltd2.27bn216.05m5.48bn16.78k25.383.24--2.421.241.2413.029.720.59161.1412.611,064,742.008.418.2016.2016.1745.2546.5914.2213.331.90--0.18630.9316.194.6816.928.03-12.0113.97
Siegfried Holding AG1.36bn136.21m5.57bn3.80k38.905.5024.464.0829.8729.87299.09211.390.70462.003.80326,556.307.066.518.647.9825.8723.2410.039.061.4014.340.321715.263.419.87-28.1618.3417.956.72
Financiere de Tubize SA0.00183.85m5.81bn--31.623.0831.62--4.134.130.0042.450.00------9.647.049.857.24------145.70----0.016120.94----3.50-20.93--11.61
Ono Pharmaceutical Co Ltd3.16bn764.23m6.01bn3.85k7.531.116.841.90253.57253.571,052.071,726.260.51172.443.65129,855,200.0012.3811.9515.1413.7374.6974.1124.2023.891.32--0.166132.2512.4111.7313.5319.95-6.7912.20
Jazz Pharmaceuticals PLC3.52bn355.36m6.20bn2.80k19.161.836.591.765.825.8257.2660.940.34570.69145.981,396,387.003.511.483.941.6289.3988.7910.144.262.022.270.60270.004.7815.19285.14-1.49-20.04--
Elanco Animal Health Inc4.04bn-1.13bn6.36bn9.30k--1.19--1.57-2.55-2.559.0912.020.30391.224.49483,010.80-8.49-3.27-9.33-3.6555.1954.28-27.94-11.531.751.110.4886--0.1367.57-1,478.21--2.74--
CSPC Pharmaceutical Group Ltd4.01bn751.69m6.37bn20.30k8.461.4413.951.590.54960.54962.933.220.69143.015.241,479,853.0013.2516.0817.6421.5771.3872.9519.1619.632.2284.540.010635.511.6612.16-3.5813.77-2.5825.33
Data as of Sep 18 2024. Currency figures normalised to Financiere de Tubize SA's reporting currency: Euro EUR

Institutional shareholders

1.13%Per cent of shares held by top holders
HolderShares% Held
BNP Paribas Asset Management Europe SASas of 29 Nov 202397.71k0.22%
Investor Asset Management BVas of 06 Sep 202471.55k0.16%
Capricorn Venture Partners NV (Investment Management)as of 31 Jul 202459.79k0.13%
Value Square NVas of 30 Jun 202456.94k0.13%
Sunline Pte Ltd.as of 28 Jun 202453.83k0.12%
Richelieu Gestionas of 30 Apr 202440.60k0.09%
Fidelity Management & Research Co. LLCas of 31 Jul 202439.16k0.09%
Degroof Petercam Asset Management SAas of 31 May 202432.95k0.07%
KBC Asset Management NVas of 31 Dec 202325.81k0.06%
Bank Nagelmackers NVas of 12 Sep 202422.12k0.05%
More ▼
Data from 31 Mar 2024 - 12 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.